Engineering Biology for Biomedicine

A UKRI:BBSRC Centre for doctoral training

EB4BM applications open4 February 2026
We are pleased to announce that applications for entry into the October 2026 Cohort are now open. Funded studentships are available to both home and international students. All studentships include: Stipend (in the range of £21,000 – £33,000), Tuition fees (covering the UKRI tuition fee amount per…

Why EB4BM

“ Our graduates bridge fundamental biological design principles with biomedical bottlenecks, delivering engineering biology for the development of new therapeutics. ”

Mark wallace

EB4BM Director

Engineering Biology for Biomedicine (EB4BM) is a transformative doctoral training programme bringing together King’s College London, the University of Leeds, and the National Physical Laboratory with 18 industry partners to train the next generation of engineering biologists.

Engineering biology applies systematic design principles to biological systems, creating programmable molecules, cells, and materials that can revolutionize how we treat disease, from designing therapies that target previously “undruggable” proteins to engineering cells that sense and respond to their environment.

Our Programme

Linking supervision in engineering biology and biomedicine, we will deliver the medicines of tomorrow.

Our Researchers

Our cohort-first approach will enable you to develop a network of researchers across the UK.

Our Projects

Choose up front a project that matches your research interests and motivation.

Bespoke interdisciplinary training spanning protein design, biomaterials engineering, AI-driven biological design, and bioprocessing for therapeutic manufacturing
Skills in critical shortage that industry partners have identified as urgently needed: designing biological systems, scaling manufacturing processes, and navigating regulatory pathways for novel biotechnologies
Deep expertise in metrology and standards for engineering biology, working with NPL to master the quality assurance and regulatory frameworks essential for clinical translation
Access to world-class facilities including NPL’s Metrology Bio-foundry (£10M), cryo-EM suites, gene therapy innovation hubs, and advanced structural biology capabilities
Direct industry experience through CASE studentships and placements with partners including AstraZeneca, Johnson & Johnson, and leading biotech companies
Career pathways into high-growth sectors with graduates equipped for roles in biotech R&D, pharmaceutical development, academic research, regulatory affairs, and entrepreneurship in a sector contributing £43.3 billion to UK GDP